BioCentury
ARTICLE | Company News

Alnylam, Sanofi deal

March 31, 2014 7:00 AM UTC

Sanofi's Genzyme Corp. unit paid Alnylam $23 million to purchase 344,448 shares of Alnylam common stock at $66.88, Alnylam's closing price on March 25, the date the shares were purchased. Under the c...